Caption Management’s Achieve Life Sciences QUIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.49M Sell
1,050,000
-125,500
-11% -$898K 0.04% 480
2026
Q2
$7.68M Buy
1,175,500
+1,145,500
+3,818% +$5.46M 0.04% 465
2026
Q1
$88.2K Hold
30,000
– – ﹤0.01% 1402
2025
Q4
$149K Sell
30,000
-170,000
-85% -$741K ﹤0.01% 1415
2025
Q3
$630K Hold
200,000
– – ﹤0.01% 1245
2025
Q2
$452K Buy
+200,000
New +$570K 0.01% 1132
2024
Q4
– Sell
-41,400
Closed -$196K – 1426
2024
Q3
$196K Sell
41,400
-66,300
-62% -$303K ﹤0.01% 1067
2024
Q2
$506K Buy
+107,700
New +$519K 0.01% 807

Other funds holding QUIT

Caption Management's QUIT Position: Q3 2026 in Review

Caption Management increased its Achieve Life Sciences (QUIT) stake by 89% in Q3 2026, buying an estimated $1.44M and bringing the position to 429,294 shares worth $3.47M. The position accounts for 0.01% of the portfolio, ranked #805.

Caption Management first reported a position in QUIT in Q4 2025 and has held it in 4 quarters since. 132 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • Caption Management held 429,294 shares of Achieve Life Sciences worth $3.47M as of Q3 2026.
  • Caption Management bought 201,561 Achieve Life Sciences shares in Q3 2026, an estimated $1.44M.
  • Achieve Life Sciences made up 0.01% of Caption Management's portfolio in Q3 2026, its #805 holding.
  • Caption Management first reported a position in Achieve Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • 132 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.